Metabolic syndrome in women with polycystic ovary syndrome

Fertility and Sterility

Volumn 86, Issue SUPPL. 1, 2006, Pages

  Essah, Paulina A ^a   Nestler, John E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dyslipidemia; metabolic syndrome; polycystic ovary syndrome

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ARTERY CALCIFICATION; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGE DISTRIBUTION; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERANDROGENISM; INSULIN RESISTANCE; METABOLIC SYNDROME X; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; PREVALENCE;

EID: 33745187408     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.04.013     Document Type: Article

References (9)

1. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation (2005)
2. Grundy S.M., Hansen B., Smith Jr. S.C., Cleeman J.I., and Kahn R.A. Clinical management of metabolic syndrome. report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109 (2004) 551-556
3. Korhonen S., Hippelainen M., Vanhala M., Heinonen S., and Niskanen L. The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women. a controlled community-based study. Fertil Steril 79 (2003) 1327-1334
4. Apridonidze T., Essah P.A., Iuorno M.J., and Nestler J.E. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90 (2005) 1929-1935
5. Dokras A., Bochner M., Hollinrake E., Markham S., Vanvoorhis B., and Jagasia D.H. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol 106 (2005) 131-137
6. Glueck C.J., Papanna R., Wang P., Goldenberg N., and Sieve-Smith L. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism 52 (2003) 908-915
7. Vural B., Caliskan E., Turkoz E., Kilic T., and Demirci A. Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome. Hum Reprod 20 (2005) 2409-2413
8. Talbott E.O., Zborowski J.V., Rager J.R., Boudreaux M.Y., Edmundowicz D.A., and Guzick D.S. Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. J Clin Endocrinol Metab 89 (2004) 5454-5461
9. Sam S., Legro R.S., Bentley-Lewis R., and Dunaif A. Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 90 (2005) 4797-4802